ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
32 hedge funds and large institutions have $3.08M invested in Acorda Therapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
32
Holding in Top 10
–
Calls
$10K
Puts
–
Top Buyers
| 1 | +$1.11M | |
| 2 | +$254K | |
| 3 | +$126K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$100K |
| 5 |
Renaissance Technologies
New York
|
+$90.4K |
Top Sellers
| 1 | -$747K | |
| 2 | -$84.7K | |
| 3 | -$65.8K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$32K |
| 5 |
Jane Street
New York
|
-$22K |